Tokyo IPO

Japanese

Modalis Therapeutics Corporation

Code Sector Market
4883 Pharmaceuticals MTH
Date of listing approval 2020/06/26
Expected Date 2020/08/03
Lead Underwriter Mizuho    
Description Research and development of gene therapy drugs using the core platform technology "Incisive CRISPR technology (CRISPR-GNDM technology)"
Listed Shares(total) 3,105,000
Trading Unit 100
New Shares 2,100,000
Existing Shares 1,005,000¡Êincl. O.A.¡Ë
Shares Outstanding PreIPO 25,100,000.00
PostIPO 27,200,000.00
Paid Up Capital PreIPO Y1,300,000,000
PostIPO Y2,075,008,000
Expected Pricing Date 2020/07/10
Book Building Start 2020/07/14
Book Building End 2020/07/20
Fix Date 2020/07/21
Offering Starts 2020/07/22
Offering Ends 2020/07/29
Expect Pricing Y1,000-Y1,200
Notional PER
(based on previous period)
167.79-201.34
Offering Price Y1,200
Offering Price PER
(based on previous period)
 - 
Offering Price PBR
(based on previous period)
7.84
Use of Funds Raised  

Financial Data

Units:Y1,000

Fiscal Year End:2017/12
Consolidated Non-consolidated
Revenue - 17,921
Current Profit - -141,200
Net Profit - -142,150
Net Assets - 1,421,735
Fiscal Year End:2018/12
Consolidated Non-consolidated
Revenue 65,297 65,297
Current Profit -213,390 -228,981
Net Profit -217,909 -229,932
Net Assets 1,201,779 1,191,802
Fiscal Year End:2019/12
Consolidated Non-consolidated
Revenue 644,500 644,500
Current Profit 146,351 128,822
Net Profit 140,528 127,899
Net Assets 3,842,542 3,819,701
Recent Quarter
2020/03
Consolidated Non-consolidated
Revenue 13,000 -
Current Profit -116,924 -
Net Profit -118,286 -
Net Assets 3,724,455 -

Per Share Units:Y1

Fiscal Year End:2017/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning - -
Equity -10.29 -3.89
Fiscal Year End:2018/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning -10.84 -14.84
Equity -11.44 -15.33
Fiscal Year End:2019/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning 5.96 153.09
Equity 5.43 152.18
Fiscal Year End:Recent Quarter
2020/03
Consolidated Non-consolidated
Dividend
Net Earning -4.71 -
Equity - -

Comment

¢£Over allotment(405,000)

Consolidated Subsidiaries

Name Address

Underwriters

Allocation Underwriter Tel
0% Nomura 03-3211-1811
75% Mizuho 03-5208-3210
11% SBI SECURITIES Co.,Ltd. 03-5562-7210
11% SMBC Nikko 03-5644-3111
1.5% Ichiyoshi 03-3555-6210
1.5% Ace 06-6267-2111

Data

Date of incorporation 2016/01/14
Company address  Tokyo 103-0026
Telephone 03-6822-4584
President  
Homepage https://www.modalistx.com/jp/
Auditor Azsa
Major Shareholders
Shareholder Name Ratio
86.62%
  17.86%
  16.07%
  8.39%
  8.39%
  3.75%
  3.57%
  2.86%
  2.68%
  2.68%
  2.59%
Number of Employees 3 as of 2020/05/31
Birth Date of Representative 1969/08/09

Comment